How can improved medication adherence promote value-based care? - Partner Content - MM+M

Value-based care has steadily gained traction in the United States. At the beginning of the century, only three states had executed value-based care programs. Since 2018, that number has grown to 48 out of 50 states. Clearly, if you provide healthcare services in today’s market, you need to help patients find ways to reduce the burden of their chronic disease and live healthier lives.
Value-based care can only be effective if patients follow their prescribed care plan including taking their medications as directed. That is why medication adherence plays an essential role in value-based care. Both high prescription drug prices and slower time-to-therapy can create barriers to medication adherence. In this article, we describe how improving medication adherence by breaking down these barriers can drive value-based care.

Related Keywords

United States ,Americans ,American ,Veradigm Rxtrueprice ,Pharmacy Benefit Management Institute ,Gallup Inc ,Accessed December ,High Drug Prices Affect ,Updated May ,Improved Medication ,Specialty Drugs ,American Journal ,Benefit Management ,Specialty Drug Benefits ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கர்கள் ,அமெரிக்கன் ,மருந்தகம் நன்மை மேலாண்மை நிறுவனம் ,பித்தப்பை இன்க் ,புதுப்பிக்கப்பட்டது இருக்கலாம் ,சிறப்பு மருந்துகள் ,அமெரிக்கன் இதழ் ,நன்மை மேலாண்மை ,